Literature DB >> 7249398

Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.

A Vincent, H A Solleveld.   

Abstract

It has been suggested in the past that Praomys (Mastomys) natalensis might be an animal model for human myasthenia gravis. This suggestion was based on the occurrence of thymomas and autoantibody to striated muscle in this animal species. Myasthenia gravis in man is associated with anti-striated muscle antibody and thymoma as well as antiacetylcholine receptor antibody. This prompted us to search for such autoantibodies in Mastomys. There was no evidence of anti-acetylcholine receptor antibody in any of the serum samples tested. The titres found in Mastomys correspond to those observed in human control sera. No difference was found in the number of alpha-bungarotoxin-binding sites at the motor endplate and in muscle extracts between animals with and without thymoma and with and without anti-striated muscle antibody. These findings lead to the conclusion that it is very unlikely that myasthenia gravis occurs with any frequency in Praomys (Mastomys) natalensis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249398      PMCID: PMC1537124     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Immunofluorescence studies on the association between a C-type oncornavirus and renal glomerulopathy in Praomys (Mastomys) natalensis.

Authors:  F G van Pelt; P Bentvelzen; J Brinkhof; A H Mannetje; C Zurcher
Journal:  Clin Immunol Immunopathol       Date:  1976-01

2.  Neuromuscular transmission after immunization against acetylcholine receptors.

Authors:  D P Green; R Miledi; A Vincent
Journal:  Proc R Soc Lond B Biol Sci       Date:  1975-04-29

3.  Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.

Authors:  J M Lindstrom; E H Lambert
Journal:  Neurology       Date:  1978-02       Impact factor: 9.910

4.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

5.  Thymomas and thymic hyperplasia in Praomys (Mastomys) natalensis. Concomitant myositis, myocarditis, and sialodacryoadenitis.

Authors:  H L Stewart; K C Snell
Journal:  J Natl Cancer Inst       Date:  1968-06       Impact factor: 13.506

6.  HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.

Authors:  H J Oosterhuis; T E Feltkamp; A L van Rossum; P M van den Berg-Loonen; L E Nijenhuis
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

7.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

8.  Spontaneous thymoma, polymyositis, and serum-autoantibodies to striated muscle in the rodent, subgenus Praomys (Mastomys) natalensis. Similarities to thymoma with myasthenia gravis in man.

Authors:  A J Strauss; K C Snell; B J Duntley; E J Soban; H L Stewart
Journal:  Lancet       Date:  1968-05-25       Impact factor: 79.321

9.  Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases.

Authors:  T E Feltkamp; A L van Rossum
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

10.  Myasthenia gravis, autoantibodies, and HL-A antigens.

Authors:  T E Feltkamp; P M van den Berg-Loonen; L E Nijenhuis; C P Engelfriet; A L van Rossum; J J van Loghem; H J Oosterhuis
Journal:  Br Med J       Date:  1974-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.